1. Home
  2. CPIX vs JYNT Comparison

CPIX vs JYNT Comparison

Compare CPIX & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

BUY

Current Price

$6.91

Market Cap

98.3M

Sector

Health Care

ML Signal

BUY

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$7.18

Market Cap

117.7M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPIX
JYNT
Founded
1999
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
98.3M
117.7M
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
CPIX
JYNT
Price
$6.91
$7.18
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
36.5K
★ 82.6K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
58.70
★ 133.93
EPS
N/A
★ 0.14
Revenue
$42,010,949.00
★ $117,696,356.00
Revenue This Year
N/A
$10.93
Revenue Next Year
N/A
$2.78
P/E Ratio
★ N/A
$50.43
Revenue Growth
★ 16.75
15.49
52 Week Low
$1.85
$7.06
52 Week High
$9.28
$10.67

Technical Indicators

Market Signals
Indicator
CPIX
JYNT
Relative Strength Index (RSI) 43.49 26.79
Support Level $5.55 N/A
Resistance Level $7.36 $9.49
Average True Range (ATR) 0.49 0.27
MACD -0.06 -0.13
Stochastic Oscillator 6.62 8.28

Price Performance

Historical Comparison
CPIX
JYNT

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.

Share on Social Networks: